- $2.73bn
- $1.48bn
- $676.17m
- 66
- 15
- 68
- 48
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 143 | 290 | 517 | 748 | 676 |
Cost of Revenue | |||||
Gross Profit | 60.5 | 118 | 232 | 320 | 330 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 202 | 337 | 679 | 970 | 959 |
Operating Profit | -58.9 | -47.1 | -162 | -221 | -283 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -58.2 | -47.6 | -165 | -185 | -231 |
Provision for Income Taxes | |||||
Net Income After Taxes | -58.2 | -47.7 | -164 | -185 | -223 |
Net Income Before Extraordinary Items | |||||
Net Income | -58.2 | -47.7 | -164 | -185 | -223 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -58.2 | -47.7 | -164 | -185 | -223 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.11 | -0.09 | -0.303 | -0.323 | -0.316 |
Dividends per Share |